Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)

The summary for the Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD): The purpose of this Notice of Funding Opportunity is to enable the continuation of the active, nationwide study, begun in 1995, of recipients of blood products from donors who are subsequently diagnosed with classic forms of Creutzfeldt-Jakob Disease (CJD) in order to assess the risk of possible transmission of such forms of CJD by blood transfusion.
Federal Grant Title: Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)
Federal Agency Name: Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CK-19-004
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.084
CFDA Descriptions: Information not provided
Current Application Deadline: March 19th, 2019
Original Application Deadline: March 19th, 2019
Posted Date: November 28th, 2018
Creation Date: November 28th, 2018
Archive Date: April 18th, 2019
Total Program Funding: $385,000
Maximum Federal Grant Award: $77,000
Minimum Federal Grant Award: $70,000
Expected Number of Awards: 1
Cost Sharing or Matching: No
Last Updated: November 28th, 2018
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Single Source Competition: Eligibility Limited to the American Red Cross
Grant Announcement Contact
Deborah Loveys
hft6@cdc.gov
Grants Policy
Similar Government Grants
Economic Modeling for HIV/AIDS, Viral Hepatitis, STD, and TB
Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings i...
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Su...
Identification, Surveillance, and Control of Vector-Borne and Zoonotic Infectious Diseases...
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
Impact of Japanese Encephalitis Vaccination in Cambodia
Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA
Network of Modeling Centers to Improve Evidence Base for Seasonal and Pandemic Influenza P...
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in P...
Multi-Site Study of the Health Implications of Exposure to PFAS-Contaminated Drinking Wate...
Advancing Infectious Disease Detection and Response in Liberia
Evaluation of Return to School Programs for Traumatic Brain Injury

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com